Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)
PHASE2
To find out if giving blinatumomab as injections under the skin and olverem...
A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma
PHASE1
Primary Objective:
• To evaluate the safety and tolerability of subcutaneo...
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies
PHASE2
Patients less than or equal to 21 years old with high-risk hematologic mali...
A Phase 1b/2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia
PHASE1
This is a single arm open-label phase 2 trial to study the safety and effic...
Status
Active Not Recruiting
Location
The University of Texas M. D. Anderson Cancer Center